Ferric Derisomaltose Generics Suppliers & Bulk Manufacturers

Available Forms: IV Infusion

Available Strengths: 100 mg/ml

Reference Brands: Monoferric® (U.S.) and Monofer® (EU))

Category: Anemia

Ferric Derisomaltose (Monoferric®/Monofer®) is a high-dose IV iron therapy used to treat iron deficiency anemia. With a 200 mg/mL concentration, it enables rapid repletion in one or two doses. It is widely used in hospitals and clinics across the U.S. and EU. Ferric Derisomaltose Generics is available in IV Infusion and strengths such as 100 mg/ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ferric Derisomaltose Generics is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ferric Derisomaltose Generics can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ferric Derisomaltose, marketed as Monoferric® in the U.S. and Monofer® in the EU, is a next-generation intravenous iron therapy used for treating iron deficiency anemia in adults, particularly when oral iron is ineffective or not tolerated. Its high-concentration formulation (200 mg/mL) allows for single high-dose administration, improving patient compliance and reducing treatment time. In the pharmaceutical B2B market, Ferric Derisomaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In both the U.S. and EU, it is supplied under GMP conditions for institutional supply, private labeling, and international distribution through licensed manufacturers and contract partners